These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31719997)

  • 41. Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamases.
    Livermore DM; Chen HY
    J Antimicrob Chemother; 1997 Sep; 40(3):335-43. PubMed ID: 9338484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A universal primer multiplex PCR method for typing of toxinogenic Pseudomonas aeruginosa.
    Shi H; Trinh Q; Xu W; Zhai B; Luo Y; Huang K
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1579-87. PubMed ID: 22923133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.
    Hassuna NA
    Surg Infect (Larchmt); 2016 Oct; 17(5):610-4. PubMed ID: 27441791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of imipenem and five other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa.
    Gerçeker AA; Otük G
    Chemotherapy; 1995; 41(5):334-6. PubMed ID: 8521734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene.
    Yahr TL; Hovey AK; Kulich SM; Frank DW
    J Bacteriol; 1995 Mar; 177(5):1169-78. PubMed ID: 7868588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subinhibitory concentrations of antibacterial drugs and Pseudomonas aeruginosa virulence factors.
    Trancassini M; Giordano A; Magni A; Cipriani P
    New Microbiol; 1993 Jul; 16(3):275-9. PubMed ID: 8366823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid detection of Pseudomonas aeruginosa targeting the toxA gene in intensive care unit patients from Beijing, China.
    Dong D; Zou D; Liu H; Yang Z; Huang S; Liu N; He X; Liu W; Huang L
    Front Microbiol; 2015; 6():1100. PubMed ID: 26500639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
    Ong CT; Kuti JL; Nicolau DP;
    Surg Infect (Larchmt); 2005; 6(4):419-26. PubMed ID: 16433606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates.
    Schiavano GF; Carloni E; Andreoni F; Magi S; Chironna M; Brandi G; Amagliani G
    PLoS One; 2017; 12(12):e0189172. PubMed ID: 29211780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary tract infection by
    Jiménez-Guerra G; Heras-Cañas V; Gutiérrez-Soto M; Del Pilar Aznarte-Padial M; Expósito-Ruiz M; Navarro-Marí JM; Gutiérrez-Fernández J
    J Med Microbiol; 2018 Jun; 67(6):790-797. PubMed ID: 29693543
    [No Abstract]   [Full Text] [Related]  

  • 51. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
    Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
    Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
    Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
    López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J
    Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    Nasu Y; Abe M; Ono N; Araki M; Horimi T; Takahashi I
    Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potentiation of imipenem by relebactam for Pseudomonas aeruginosa from bacteraemia and respiratory infections.
    Horner C; Mushtaq S; Livermore DM;
    J Antimicrob Chemother; 2019 Jul; 74(7):1940-1944. PubMed ID: 31032858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene.
    Kainuma A; Momiyama K; Kimura T; Akiyama K; Inoue K; Naito Y; Kinoshita M; Shimizu M; Kato H; Shime N; Fujita N; Sawa T
    J Infect Chemother; 2018 Aug; 24(8):615-622. PubMed ID: 29628388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
    Jaccard C; Troillet N; Harbarth S; Zanetti G; Aymon D; Schneider R; Chiolero R; Ricou B; Romand J; Huber O; Ambrosetti P; Praz G; Lew D; Bille J; Glauser MP; Cometta A
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2966-72. PubMed ID: 9797234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
    Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
    J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antimicrobial susceptibility of phenotypically extended spectrum beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii isolates].
    Metan G; Zarakolu P; Hasçelik G; Akova M
    Mikrobiyol Bul; 2006; 40(1-2):23-8. PubMed ID: 16775953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.
    Ozgumus OB; Caylan R; Tosun I; Sandalli C; Aydin K; Koksal I
    Microb Drug Resist; 2007; 13(3):191-8. PubMed ID: 17949306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.